Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 2 · 66.7%High 0 · 0%

PPI triple therapy for 14 days vs 10 days

Number of participants reporting an adverse event · patients with Helicobacter pylori infection

PPI triple therapy for 14 days showed no clear difference in patients with adverse events, regardless of regimen and dose compared with 10 days (low certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 1.01 [0.79, 1.29]
5 studies · 789 participants
Low

PPI triple therapy for 14 days vs 7 days

Number of participants reporting an adverse event · patients with Helicobacter pylori infection

PPI triple therapy for 14 days probably leads to higher patients with adverse events, regardless of regimen and dose compared with 7 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 1.2 [1.06, 1.37]
25 studies · 3971 participants
Moderate

PPI triple therapy for 10 days vs 7 days

Number of participants reporting an adverse event · patients with Helicobacter pylori infection

PPI triple therapy for 10 days showed no clear difference in patients with adverse events, regardless of regimen and dose compared with 7 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 1.06 [0.87, 1.3]
11 studies · 2089 participants
Moderate